Novasep Holding SAS-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Novasep Holding SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013937
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Novasep Holding SAS (Novasep), formerly Groupe Novasep SAS is a pharmaceutical company which offers services in molecule production and purification for life science and chemical industries. The company offers contract manufacturing and development, custom manufacturing, process engineering, scale-up services, supply of equipment and improvement programs. It offers generic APIs and intermediates, bio-pharma equipment, chemicals and polymers, mineral membranes, organic nanofiltration membranes, and chromatography and ion exchange resins. Novasep also carries out purification processes for fermentation and chemical commodities. The company caters to agrochemicals, biopharmaceuticals, fine chemicals, fermentation and chemical commodities; food ingredients, functional ingredients and pharmaceutical sectors. It operates in Europe, the US and Asia. Novasep is headquartered in Lyon, France.

Novasep Holding SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Novasep Holding SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Novasep Holding SAS, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Novasep Enters into Partnership with Advanced Biotherapeutics Consulting 10
Groupe Novasep Expands Its Agreement With instrAction 11
Acquisition 12
Repligen Acquires TangenX Technology from Novasep Holding for USD39 Million 12
Novasep Holding SAS – Key Competitors 13
Novasep Holding SAS – Key Employees 14
Novasep Holding SAS – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 17
Strategy And Business Planning 17
Feb 23, 2017: Novasep Opens €11M New Antibody-drug Conjugate (ADC) Bioconjugation Unit 17
Jun 02, 2016: Novasep opens kilo lab extension at US facility 18
Jan 28, 2016: Novasep adds synthesis and kilo lab extensions to US facility 19
Financial Announcements 20
May 31, 2017: Novasep Announces 2016 Financial Results 20
Corporate Communications 21
Mar 07, 2017: Novasep appoints Xavier de Saint Guilhem as Chief Financial Officer 21
Legal and Regulatory 22
Dec 20, 2016: Three Novasep custom manufacturing sites renew FDA approval in 2016 22
Other Significant Developments 23
Oct 24, 2017: Novasep Invests 4 Million Euros to Expand Its Cryogenic Production Capacity 23
Feb 13, 2017: Novasep Invests in a €27m Viral Vector Production Facility 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Novasep Holding SAS, Pharmaceuticals & Healthcare, Key Facts 2
Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Novasep Holding SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Novasep Holding SAS, Deals By Therapy Area, 2011 to YTD 2017 8
Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Novasep Enters into Partnership with Advanced Biotherapeutics Consulting 10
Groupe Novasep Expands Its Agreement With instrAction 11
Repligen Acquires TangenX Technology from Novasep Holding for USD39 Million 12
Novasep Holding SAS, Key Competitors 13
Novasep Holding SAS, Key Employees 14
Novasep Holding SAS, Other Locations 15
Novasep Holding SAS, Subsidiaries 15

★海外企業調査レポート[Novasep Holding SAS-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Santen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Santen Inc (Santen), a subsidiary of Santen Pharmaceutical Co Ltd is a developer, manufacturer and distributor of ophthalmic pharmaceutical products. The company offers products in therapeutic areas such as retinal disorders, glaucoma and corneal diseases. It conducts diagnosis on uveitis co …
  • Nidek Co Ltd:製品パイプライン分析
    Summary Nidek Co Ltd (Nidek) is a medical device company that designs, manufactures, distributes and leases ophthalmic and diagnostic equipment. Its products category encompasses ophthalmology and optometry software for advanced angioscan; lens edging technology for manufacturing eyeglasses, and sem …
  • Hareon Solar Technology Co Ltd (600401):電力:M&Aディール及び事業提携情報
    Summary Hareon Solar Technology Co Ltd (Hareon Solar) is a renewable energy company that manufactures and markets solar energy products. The company offers silicon cells and solar modules. Its products portfolio includes mono crystalline silicon solar cells, poly crystalline silicon solar cells, pol …
  • China CITIC Bank Corporation Limited:企業のM&A・事業提携・投資動向
    China CITIC Bank Corporation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China CITIC Bank Corporation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Brain Resource Ltd (BRC):企業の財務・戦略的SWOT分析
    Summary Brain Resource Ltd (BRL) is a healthcare service provider that offers therapies. The company carries out research and development of brain products. Its products comprise iSPOT, Total Brain and MyBrainSolutions. BRL’s MyBrainSolutions is a brain health solution to know and train brain for pe …
  • PRA Health Sciences Inc (PRAH)-製薬・医療分野:企業M&A・提携分析
    Summary PRA Health Sciences Inc (PRA) is a contract research organization(CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometric …
  • Impinj Inc (PI):企業の財務・戦略的SWOT分析
    Impinj Inc (PI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Community Health Systems Inc (CYH):製薬・医療:M&Aディール及び事業提携情報
    Summary Community Health Systems Inc. (CHS) is an operator of general acute care hospitals and outpatient facilities in communities. The company’s services include general acute care services, emergency room services, general and specialty surgery, critical care, internal medicine, obstetrics and di …
  • LKQ Corporation:企業の戦略・SWOT・財務情報
    LKQ Corporation - Strategy, SWOT and Corporate Finance Report Summary LKQ Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Continental Resources, Inc.:企業の戦略・SWOT・財務分析
    Continental Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Continental Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Volt Information Sciences Inc (VOLT):企業の財務・戦略的SWOT分析
    Volt Information Sciences Inc (VOLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Salfacorp SA:企業の戦略・SWOT・財務分析
    Salfacorp SA - Strategy, SWOT and Corporate Finance Report Summary Salfacorp SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • The Interpublic Group of Companies, Inc.:企業の戦略・SWOT・財務情報
    The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • T. Rowe Price Group, Inc.:企業のM&A・事業提携・投資動向
    T. Rowe Price Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's T. Rowe Price Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Host Hotels & Resorts Inc (HST):企業の財務・戦略的SWOT分析
    Host Hotels & Resorts Inc (HST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Northern Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Northern Biologics Inc (Northern Biologics) is a biotechnology company, which develops antibody-based- immuno-oncology medicines for treating cancers. Its pipeline product portfolio includes MSC-1, a first-in-class humanized antibody targeting leukemia inhibitory factor (LIF), a major immuno …
  • Cipla Limited:戦略・SWOT・企業財務分析
    Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tennessee Valley Authority:電力:M&Aディール及び事業提携情報
    Summary Tennessee Valley Authority (TVA) is a corporate agency providing electricity for business customers, local power companies and distributors. The agency generates power using diverse sources of energy such as hydro, nuclear, coal, diesel generator and other renewable based power plants. TVA p …
  • FUJIFILM Holdings Corporation:企業の戦略・SWOT・財務分析
    FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • African Development Bank Group:企業の戦略的SWOT分析
    African Development Bank Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆